Dr. Andrew D. Atiemo, MD

Dr. Atiemo practices at EntireCare Rehab & Sports Medicine - West Flagstaff in Flagstaff, Arizona.

Dr. Atiemo's NPI, 1285678748, was assigned on June 15, 2006. Dr. Atiemo graduated from Harvard Medical School in 2000. Dr. Atiemo holds Arizona license 36914.

Dr. Atiemo's primary practice is EntireCare Rehab & Sports Medicine - West Flagstaff, at 2000 S Thompson St, Flagstaff, AZ 86001. The practice phone is (717) 972-1100.

Dr. Atiemo's primary practice is EntireCare Rehab & Sports Medicine - West Flagstaff in Flagstaff, Arizona. Dr. Atiemo is also affiliated with Flagstaff Medical Center. The medical group on file is Northern Arizona Healthcare. Dmand AI also links Dr. Atiemo to 4 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Atiemo practices, 9 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Atiemo's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Atiemo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Atiemo's licenses on file in 3 states: Arizona, Maryland and Massachusetts.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Atiemo treats.

CMS data shows 5,473 Medicare services from Dr. Atiemo across 38 procedure codes in 2024, for 2,155 Medicare patients. Medicare paid $289,842 for them.

CMS counts 2,155 Medicare patients who saw Dr. Atiemo in 2024. The largest group is 65 to 74, with 939 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Atiemo's median patient age at 68, with 44% women.

In 2024, Dr. Atiemo wrote 1,633 Medicare Part D claims for 313 patients. 82% of them were for generic drugs. CMS names the drug for 1,492 of them, across 24 drugs with 11 or more claims each, at $236,423 in total drug cost. In 2023, CMS named 1,590 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Atiemo for performance year 2024, reported as part of a group. Dr. Atiemo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Atiemo as offering telehealth. CMS counts 16 procedures of coronary angioplasty and stenting by Dr. Atiemo, more than 42% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Atiemo in 2007. The most frequent topics are Angioplasty, Balloon, Coronary, Myocardial Infarction and Platelet Aggregation Inhibitors. Dr. Atiemo has published most often in J Thromb Thrombolysis. Dr. Atiemo's most frequent co-author is Parin Parikh, MD.

CMS Open Payments shows 238 general payments to Dr. Atiemo from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 77% of the total. Abbott Laboratories paid the most, $2,102.

Dmand AI lists 1 award for Dr. Atiemo.

Dr. Atiemo graduated from Harvard Medical School in 2000. Dr. Atiemo is a member of ACC.

Dr. Atiemo is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.